Research Paper Volume 15, Issue 24 pp 15134—15160
Experimental validation and pan-cancer analysis identified COL10A1 as a novel oncogene and potential therapeutic target in prostate cancer
Figure 8. Correlation of COL10A1 expression levels with immune cell infiltration in the TIMER database. Correlation between six immune cell infiltration scores (B cell, CD4+ T cell, CD8+ T cell, neutrophil, macrophage, dendritic cell) and COL10A1 mRNA expression in Kidney renal clear cell carcinoma (KIRC), Kidney renal papillary cell carcinoma (KIRP), Prostate adenocarcinoma (PRAD), and Uterine corpus endometrial carcinoma (UCEC). (Spearman correlation test, p < 0.05 was considered significant).